Document Classification

Section Type: RESULTS

Text: Before and 13 weeks after the treatment, symptom scores, peak flow (PEF), and peak flow rate (PEFR) for group A were (1. 8 + / - 0. 9) and (0. 10 + / - 0. 30), (295 + / - 98) L/min and (444 + / - 150) L/min, (22 + / - 8) % and (9 + / - 3) % respectively, and those for group B were (1. 90 + / - 0. 70) and (0. 10 + / - 0. 30), (328 + / - 129) L/min and (441 + / - 146) L/min, (24 + / - 7) % and (9 + / - 3) % respectively, which were remarkably improved in both groups (P < 0. 01), and bronchial provocation responsiveness to histamine tests (BHR) in both groups were also improved significantly (P < 0. 01).